Salivary cortisol in children with asthma and/or rhinitis: effect of topical steroids and correlation with symptoms and lungfunction

Salivary cortisol in children with asthma and/or rhinitis: effect of topical steroids and correlation with symptoms and lungfunction - Effect of topical steroids on salivary cortisol level in children

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34524

Enrollment

Registered

2010-09-06

Start date

2011-03-03

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adrenal function cortisol level

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: children 6-18 years newly referred children who are diagnosed with asthma and/or rhinitis and who are not already using topical steroids children with stable asthma and/or rhinitis in whom topical steroids can be tapered down to zero according to international guidelines

Exclusion criteria

Exclusion criteria: informed consent is not obtained if a child is unwilling to participate during the study a chronic medical condition other than asthma and/or rhinitis use of oral steroids in the past 3 months use of concurrent medication which may potentially affect steroidmetabolism

Design outcomes

Primary

Measure	Time frame
difference in salivary cortisol level before and during or after treatment with topical steroids	—

Secondary

Measure	Time frame
correlation of salivary cortisol, symptoms of asthma, and lungfunction	—

Countries

Netherlands

Outcome results